Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation

A breakthrough in oncology research was the discovery of doxorubicin (Dox) in the 1960’s. Unlike other chemotherapy drugs, Dox was determined to have a greater therapeutic index. Since its discovery, Dox has, in part, contributed to the 5–10-year survival increase in cancer patient outcomes. Unfortu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangweni, Nonhlakanipho F., Gabuza, Kwazi, Huisamen, Barbara, Mabasa, Lawrence, van Vuuren, Derick, Johnson, Rabia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095530/
https://www.ncbi.nlm.nih.gov/pubmed/35333943
http://dx.doi.org/10.1007/s00204-022-03262-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095530/
https://www.ncbi.nlm.nih.gov/pubmed/35333943
http://dx.doi.org/10.1007/s00204-022-03262-w

Ejemplares similares